Security key
25253X207
DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC)
CUSIP: 25253X207
Q1 2021 13F Holders as of 31 Mar 2021
- Security type / class
- Equity / Voting Common Shares, no par value
- Total 13F shares
- 5,694,347
- Total 13F value
- $88,119,211
- Share change
- -289,912
- SEC-reported price per share
- $9.15
- Number of holders
- 38
- Value change
- +$33,217,401
- Number of buys
- 22
- Number of sells
- 13
- Shares outstanding
- 52,272,727
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2021
Institutions
38
Top holders
10
DMAC full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2021
Previous quarter: Q4 2020
DiaMedica Therapeutics Inc. SEC filings
DiaMedica Therapeutics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 25253X207
Recent filing periods:
Ownership snapshot
Top reported holders of DMAC - DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Stonepine Capital Managem...
Disclosed value leader
Stonepine Capital Managem...
Comparable rows
15/15
Latest evidence
31 Dec 2020
13F
Lead comparable stake: 1.8%
Showing 1-6 of 15 holder rows.
Quick read
Stonepine Capital Management, LLC leads the comparable SEC ownership view at 1.8%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Stonepine Capital Management, LLC's linked filing trail.
Comparable ownership
Top 5
Stonepine Capital Management, LLC
1.8%
Corriente Advisors, LLC
1.5%
Point72 Asset Management, L.P.
1.5%
VANGUARD GROUP INC
1.5%
Manatuck Hill Partners, LLC
1.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Stonepine Capital Management, LLC |
13F
Company
|
1.8%
|
$9,633,000
950,000 shares
|
— | 31 Dec 2020 |
| Corriente Advisors, LLC |
13F
Company
|
1.5%
|
$8,182,000
806,900 shares
|
— | 31 Dec 2020 |
| Point72 Asset Management, L.P. |
13F
Company
|
1.5%
|
$8,112,000
800,000 shares
|
— | 31 Dec 2020 |
| VANGUARD GROUP INC |
13F
Company
|
1.5%
|
$7,908,000
779,898 shares
|
— | 31 Dec 2020 |
| Manatuck Hill Partners, LLC |
13F
Company
|
1.1%
|
$5,795,000
571,500 shares
|
— | 31 Dec 2020 |
| Granite Point Capital Management, L.P. |
13F
Company
|
1%
|
$5,545,000
546,855 shares
|
— | 31 Dec 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
38
Shares
5,694,347
Rows available
38
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2021 vs Q4 2020 Across Filers
Q4 2020 holders
34
Q1 2021 holders
38
Holder diff
4
| Investor | Q4 2020 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q4 2020 value | Q1 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend